Synthetics USA is an international fine and specialty chemical consultant company. Our principal expertise is sourcing products with applications in pharmaceutical, medical imaging, electronic, and fine & specialty chemical markets. Other services include business development (product-based or customer acquisition) for manufacturers through our strong network within the chemical industry, combined with high-level market research and analysis. We have strategic relationships with manufacturers in China, India, and the USA that allow us to offer custom solutions to each project we handle. In January 2020, Synthetics USA became the majority stakeholder in Verdimine, LLC, an early-stage, specialty green chemical company focused on the sustainable production of imines, oximes, semicarbazones, and quinoxaline derivatives. Synthetics USA will direct the business development, sales, and marketing representation for Verdimine in the North American marketplace. Synthetics USA also represents companies with capabilities including, but not limited to: Early phase through commercial scale cGMP pharmaceutical API's Fermentation products, including antibody-drug conjugate cytotoxic payloads High purity chemicals used in medical imaging, UV stabilizers, & cosmetics Process research and development for targeted molecules (lab scale) Cryogenic reactions